Pharmacovigilance and Adverse Drug Reactions (Adrs) Practice of Healthcare Professionals

被引:0
作者
Mohamed, Elsadig Yousif [1 ]
机构
[1] Majmaah Univ, Coll Med, Publ Hlth, Al Majmaah 11952, Saudi Arabia
来源
PAKISTAN JOURNAL OF MEDICAL & HEALTH SCIENCES | 2021年 / 15卷 / 12期
关键词
Pharmacovigilance; Adverse Drug Reactions; Healthcare Professionals; KNOWLEDGE; AWARENESS; ATTITUDE;
D O I
10.53350/pjmhs2115123473
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim: To assess pharmacovigilance and adverse drug reactions practice of healthcare professionals in Ribat University Hospital, Khartoum, Sudan. Methods: This was a cross-sectional study to evaluate pharmacovigilance and ADRs practice among physicians, pharmacist and nurses working in the National Ribat University, Khartoum, Sudan. The sample size was calculated as 100. Data were collected by a pre-tested questionnaire after obtaining ethics approval. Data analysis was performed by SPSS software. Results: The HCPs who acquired good and poor pharmacovigilance practice were 16 (16%) and 84 (84%) respectively. Ninety-eight (98%) of the healthcare professionals have ever experienced ADR in their patients during professional practice. Ninety-four (94%) have ever seen ADR reporting form. Forty (40%) have ever reported ADR to the pharmacovigilance center. Pharmacists, Physicians and nurses with good practice were30.8%, 18.4% and 7.9% respectively. Conclusion: Most healthcare professionals acquire good pharmacovigilance practice. The pharmacist acquires higher level of pharmacovigilance practice followed by physicians and nurses. Healthcare professionals with shorter years of experience have significantly higher pharmacovigilance practice.
引用
收藏
页码:3473 / 3475
页数:3
相关论文
共 21 条
[1]  
Albadawi TE, 2019, J RES MED DENT SCI, V7, P137
[2]   Knowledge, Practice and Attitudes Toward Pharmacovigilance and Adverse Drug Reactions Reporting Process Among Health Care Providers in Dammam, Saudi Arabia [J].
Ali, Mohammad Daud ;
Hassan, Yousif Amin ;
Ahmad, Ayaz ;
Alaqel, Orjwan ;
Al-Harbi, Hadeel ;
Al-Suhaimi, Nada Mohammed .
CURRENT DRUG SAFETY, 2018, 13 (01) :21-25
[3]   Healthcare professionals' awareness and knowledge of adverse drug reactions and pharmacovigilance [J].
Almandil, Noor B. .
SAUDI MEDICAL JOURNAL, 2016, 37 (12) :1359-1364
[4]  
Alsbou M., 2017, BIOMED PHARMACOL J, V10, P319, DOI [DOI 10.13005/bpj/1112, 10.13005/bpj/1112]
[5]  
[Anonymous], 2002, Safety of Medicines: A Guide to Detecting and Reporting Adverse Drug Reactions: Why Health Professionals Need to Take Action
[6]   Distinguishing Hazards and Harms, Adverse Drug Effects and Adverse Drug Reactions Implications for Drug Development, Clinical Trials, Pharmacovigilance, Biomarkers, and Monitoring [J].
Aronson, Jeffrey K. .
DRUG SAFETY, 2013, 36 (03) :147-153
[7]   Clarification of terminology in drug safety [J].
Aronson, JK ;
Ferner, RE .
DRUG SAFETY, 2005, 28 (10) :851-870
[8]   Adverse drug reactions: definitions, diagnosis, and management [J].
Edwards, IR ;
Aronson, JK .
LANCET, 2000, 356 (9237) :1255-1259
[9]   Awareness and Reporting of Adverse Drug Reactions Among Health Care Professionals in Sudan [J].
Elnour, Asim Ahmed ;
Ahmed, Ahmed Dahab ;
Yousif, Mirghani Abd Elrahman ;
Shehab, Abdulla .
JOINT COMMISSION JOURNAL ON QUALITY AND PATIENT SAFETY, 2009, 35 (06) :324-+
[10]  
European Medicines Agency, 2014, EMA8763332011